Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Price Behavior
Key Price Behavior Insights: ⢠Higher lows ⢠Dip rebound ⢠Resistance stall Support Level: $52.5-$52.8 Resistance Level: $53.6 CNO has shown a mild uptrend over the last month, with higher lows and dip-buying support, but it is still stalling just below $53.6 resistance, so the setup is constructive but not yet a breakout.
Sentiment & News
Key News Insights: ⢠Momentum appeal ⢠Sector tailwinds ⢠Earnings ahead CNO Financial is drawing sustained momentum-investor interest alongside favorable insurance-sector tailwinds, with Q2 2026 results due after the market close on July 30.
AI Summary
CNO now looks more like a rerating story than a cheap defensive insurer, with upside hinging on sustained earnings quality, LTC execution, and continued support from elevated Treasury yields, while the main risk is that the stock has already priced in much of the improvement and could compress if results merely track the macro tailwind.
Description
CNO Financial Group, through its subsidiaries, underwrites and administers a range of life, health and annuity products for middle-income and senior customers in the United States, including Medicare-related coverage, supplemental health and long-term care offerings. The company distributes its products via agents, independent producers, direct channels and worksite/group relationships, and markets under the Bankers Life, Washington National and Colonial Penn brands. Founded in 1979, CNO is headquartered in Carmel, Indiana.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jul 31 | Aug 7 | CNO | CNO Financial Group, Inc. | Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation. | Active | +0.0% |